Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20431 AL 20445

Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts

Ta M, Blauwendraat C, Antar T, Leonard HL, Singleton AB, Nalls MA, Iwaki H; Alzheimer's Disease Neuroimaging Initiative (ADNI); and the Fox Investigation for New Discovery of Biomarkers.

Mov Disord. 2023 Sep;38(9):1697-1705. doi: 10.1002/mds.29511. Epub 2023 Aug 4.

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis

Bittner N, Funk CSM, Schmidt A, Bermpohl F, Brandl EJ, Algharably EEA, Kreutz R, Riemer TG.

Drugs Aging. 2023 Nov;40(11):953-964. doi: 10.1007/s40266-023-01065-x. Epub 2023 Sep 8.

Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients

Fang C, Hernandez P, Liow K, Damiano E, Zetterberg H, Blennow K, Feng D, Chen M, Maccecchini M.

J Prev Alzheimers Dis. 2023;10(1):25-33. doi: 10.14283/jpad.2022.84.

Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis

Corniello C, Dono F, Evangelista G, Consoli S, De Angelis S, Cipollone S, Liviello D, Polito G, Melchiorre S, Russo M, Granzotto A, Anzellotti F, Onofrj M, Thomas A, Sensi SL.

Seizure. 2023 Jul;109:62-67. doi: 10.1016/j.seizure.2023.05.017. Epub 2023 May 21.

Rare causes of dystonia-parkinsonism with cognitive impairment, behavioral abnormalities, and voiceless whispering stereotypies: Describing the long-term evolution of the neurological phenotype in a patient with the PSEN2 Ile149Thr variant

Romito LM, Prioni S, Braccia A, Catania M, Elia AE, Dondi F, Lucchini S, Bertagna F, Piacentini SHMJ, Eleopra R, Di Fede G.

J Neurol Sci. 2023 Nov 15;454:120846. doi: 10.1016/j.jns.2023.120846. Epub 2023 Oct 20.

[Abnormal posture of the trunk related to donepezil hydrochloride: report of 2 cases]

Ueda A, Komatsu K, Takahashi M.

Rinsho Shinkeigaku. 2023 Feb 25;63(2):85-91. doi: 10.5692/clinicalneurol.cn-001792. Epub 2023 Jan 31.

An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing

Sadhukhan D, Mallick A, Mishra S, Mukherjee A, Biswas A, Hui SP, Biswas A.

Alzheimer Dis Assoc Disord. 2023 Apr-Jun 01;37(2):164-167. doi: 10.1097/WAD.0000000000000546. Epub 2023 May 8.

Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE)

Sisodia V, Swinnen BEKS, Dijk JM, Verwijk E, van Rooijen G, Lemstra AW, Schuurman PR, de Bie RMA.

BMC Neurol. 2023 Apr 21;23(1):160. doi: 10.1186/s12883-023-03142-5.

Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

Birajdar SV, Mazahir F, Alam MI, Kumar A, Yadav AK.

Eur J Pharmacol. 2023 Dec 15;961:176117. doi: 10.1016/j.ejphar.2023.176117. Epub 2023 Oct 30.

Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases

Lizama BN, Kahle J, Catalano SM, Caggiano AO, Grundman M, Hamby ME.

Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.

Epigallocatechin Gallate: A Multifaceted Molecule for Neurological Disorders and Neurotropic Viral Infections

Rani A, Saini V, Patra P, Prashar T, Pandey RK, Mishra A, Jha HC.

ACS Chem Neurosci. 2023 Sep 6;14(17):2968-2980. doi: 10.1021/acschemneuro.3c00368. Epub 2023 Aug 17.

The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target

Jaberi KR, Alamdari-Palangi V, Jaberi AR, Esmaeli Z, Shakeri A, Gheibi Hayat SM, Tajbakhsh A, Savardashtaki A.

Curr Mol Med. 2023;23(9):863-875. doi: 10.2174/1566524023666220817145638.

Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases

Eskandari S, Rezayof A, Asghari SM, Hashemizadeh S.

Neuropeptides. 2023 Oct;101:102356. doi: 10.1016/j.npep.2023.102356. Epub 2023 Jun 23.

Uncovering the Significance of STEP61 in Alzheimer's Disease: Structure, Substrates, and Interactome

Bagwe PV, Deshpande RD, Juhasz G, Sathaye S, Joshi SV.

Cell Mol Neurobiol. 2023 Oct;43(7):3099-3113. doi: 10.1007/s10571-023-01364-2. Epub 2023 May 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias